Passeri Daniel R
- SEC CIK
- 0001190121
No open-market purchases or sales filed in the past year.
Current role at each company
- CUE Cue Biopharma, Inc.CHIEF EXECUTIVE OFFICERas of Mar 25, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Passeri Daniel R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2021 (view filing) | Sep 24 | 3 days | Passeri Daniel RCHIEF EXECUTIVE OFFICER | PPurchase | +3.40K | $14.72 | +$50.0K | +6.5%55.4K after | |
| Aug 16, 2023 (view filing) | Aug 14 | 2 days | Passeri Daniel RCHIEF EXECUTIVE OFFICER | PPurchase | +3.00K | $2.86 | +$8.58K | +2.3%134.6K after | |
| Dec 18, 2024 (view filing) | Dec 16 | 2 days | Passeri Daniel RCHIEF EXECUTIVE OFFICER | PPurchase | +30.0K | $1.03 | +$30.9K | +22.3%164.6K after |